Form 4 for BJDX Bluejay Diagnostics, Inc.
Accepted 2022-03-21 00:00:00 ET · period of report 2022-03-17 · accession 0001213900-22-013761 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-21 | 2022-03-17 | BJDX | Dey Svetlana | Dir, 10% | P - Purchase | $1.18 | +10.0K | 10.0K | New | +$11.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-17 | P | A | 10,000 | $1.18 | 10,000 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.17 to $1.19. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Does not include 4,091,356 shares held by Lana Management & Business Research International, LLC, an entity owned by Mr. Indranil Dey and Ms. Svetlana Dey. Ms. Dey has voting and dispositive power over the shares held by such entity. |